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Public Healthcare and the Limits to
a Canadian-Style Inclusive Trade
Agenda 





1 In  response  to  the  anti-globalization  backlash,  Canada  has  been  developing  a
Progressive Trade Agenda (PTA) or what has more recently been referred to as "an
inclusive  approach"  to  trade  (Government  of  Canada,  2020).  This  agenda,  which  is
similar to many inclusive or sustainable trade projects developed by multinational fora
(the WTO, the World Bank…) and the European Commission, aims to respond to the
rejection of globalization, which has primarily been criticized on the grounds that the
gains from ever freer trade have not been shared evenly. Moreover, such a progressive
agenda also seeks to alleviate the detrimental effects on the environment and health.
Trade policy-making has thus been aimed at  reflecting such an inclusive stance.  In
Britain,  there has  also been some support  for  the development of  a  Canadian-style
progressive  trade  policy  agenda  post-Brexit  (Department  for  International  Trade,
2018). 
2 One of the key tenets of Canada’s inclusive approach to trade is the safeguarding of the
rights of  national  governments to regulate in the area of  public  services,  including
health  services.  The  government  underlines,  for  example,  that  the  Canada-EU
Comprehensive Economic and Trade Agreement (CETA) "protects the ability of Canada
to regulate and legislate to achieve legitimate public policy objectives in public health"
(Government of Canada, 2020). In a consultation report for the UK’s post-Brexit trade
deals,  the  UK  Government  stated that  it  "is  committed  to  maintaining  our  high
standards for consumers, workers, and the environment, and to protecting our public
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services,  in  any  future  trade  agreements  that  we  conclude."  (Department  for
International  Trade,  2018).  However,  the  extent  to  which  such  an  agenda  protects
public healthcare provision is far from certain. 
3 The  policy  space  for  national  governments  in  the  area  of  health  has  been  firmly
established in free trade agreements and clauses included in both multinational and
new  generation  trade  deals  to  exclude  public  health  services  from  the  trade
liberalization  process.  This  does  not  necessarily  mean  that  healthcare  services  are
protected, essentially because the changing nature of modern economies has resulted
in a blurring of public and private activities. Yet trade policy-makers fail to take into
account  such  complexities  when  setting  provisions  to  protect  public  healthcare  in
trade deals. Official discourse, provisions in FTAs, and more generally trade policy may
aim at excluding public health services in line with the progressive trade agenda, but
the practice of trade tends to provide scope for inclusion and thus the furthering of
international trade and investment in this sensitive sector. 
4 It would seem appropriate at present, faced with the Covid-19 pandemic, to consider
the  impacts  of  healthcare  marketization  from  an  international  perspective  and  to
revisit  the  literature  on  the  inherent  dangers  of  furthering  healthcare  trade  and
investment.  The Covid-19 pandemic has highlighted the weaknesses of  many public
healthcare  systems  and  the  need  for  greater  investment.  In  countries  in  which
healthcare is highly dependent on the private sector, such as the USA, the pandemic
has  shown the  limits  to  this  mode  of  supply.  The  US  system has  been exposed  as
dysfunctional, lacking the protective gear, and highly unequal, with poorer hospitals
facing bankruptcy (Hook and Kuchler, 2020). Yet some observers have promoted the
further development of the private supply of healthcare services through international
trade. They lend support to the furthering of cross-border healthcare supply to fight
the pandemic (see Gillson and Muramatsu, 2020). 
5 The purpose of this article is to compare the cases of the UK and Canada concerning the
furthering of trade and investment in health services and to consider the impact on
publicly  administered  healthcare  systems.  This  paper  draws  on  theoretical  and
empirical insights from both health policy research and international political science
to  analyze  the  potential  effects  of  further  trade  openness  on  public  healthcare
provision in two countries facing similar challenges. This article is the first to compare
the  cases  of  the  UK  and  Canada  for  health  services  trade  challenges.  These  two
countries are good points of comparison because they both have healthcare systems
free at the point of use, but are becoming increasingly reliant on private sector income
from international suppliers, which has the potential to disrupt the public provision of
healthcare.
6 The paper draws on IPE structuralist literature because it is, in essence, supporting a
basic structuralist tenet that more trade leads to structural change in the periphery
and in this case the reconfiguration of the health market. It will review some of the
major  concerns  raised in  the  literature  for  public  healthcare :  lock-in liberalization
through  ratchet  and  negative  listing,  transparency  and  anti-trust  clauses,  and  the
potential for IPR clauses and ISDS mechanisms to result in escalating prices for the
medication in both Canada and Britain. However, it goes further than this literature
and  uses  other  desk  research  to  extensively  examine  the  furthering  of  trade  and
investment  in  private  health  services  and the  extent  to  which this  can impact  the
delivery of public healthcare services.
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7 Several academic papers have already considered the constraints that commitments in
FTAs place on the ability to deliver public health services (De ville and Siles Brugges,
2015 ; Maier de Kruiff et al., 2016). However, there are fewer papers that analyze the
broader reconfiguration of the market for healthcare that this implies. Nor indeed have
many papers  looked at  the  "shadow processes"  beyond FTAs that  are  underway in
Canada  and  the  UK  to  free  up  trade  and  international  investment  in  healthcare
services. Public and private stakeholders are engaging in the furthering of trade and
investment in health services thanks to the liberalization of public services. As a result,
there  would  appear  to  be  significant  risks  to  the  equitable  supply  of  high-quality
healthcare services.
8 This paper thus starts by considering the role of the market in public services. It then
describes  the  liberalization  process  which  has  enabled  the  furthering  of  trade  and
investment in public health services and the locking in of liberalization as a result of
trade deals. It points to the particularly harmful effects this can have, for example by
resulting in unaffordable essential medicines for populations. It shows that, beyond the
locking-in process, state support for expanding the private health market means that
the market for public health services is still at risk even if carve-outs for public services
are included in progressive Canadian-style FTAs.
 
02. Market mechanisms and public services 
9 Whether it be in health, education, transport, or the like, "public" has become a highly
contested  notion.  In  practice,  the  division  between public  and  private  is  debatable
when  we  consider  service  delivery  and  service  outputs.  The  traditional  concept  of
public in neo-classical literature is defined, according to Samuelson (1954), as services
or goods that are non-rivalrous and non-excludable. Non-rivalrous because they can be
consumed by an unlimited number of people without depletion and non-excludable
because  they  are  available  to  all.  However,  nowadays  most  services  or  goods  only
partially conform to this model. Liberal theory creates a dualism between the state and
the market. Yet the two are not necessarily exclusive of one another. Markets can be
set up, managed, owned by governments or state agencies for profit. Public and private
goods  can  be  seen  to  be  inter-dependent.  As  Teixiera  et  al. (2004)  underline,  our
understanding of public and private becomes blurred as more stakeholders, such as
semi-public organizations, independent agencies, regulatory bodies, or public-private
networks are involved in the provision of public services. 
10 Financial  considerations  have  also  meant  the  principle  of  margin,  i.e.  the  cost  or
benefit incurred with changing allocations of resources is sometimes applied to public
services,  even  if  such  analysis  raises  many  difficulties.  For  example,  in  the  health
sector, public health systems may take into consideration the extra cost incurred by
producing one unit of production and if the marginal cost rises above the average cost,
health  policymakers  will  decide  whether  it  is  worthwhile  providing  such  services.
Efficiency also comes into play in current health systems. The mantra of governments
over the last  decades has indeed been to make the best  use of  scarce resources to
deliver health to the population. 
11 Concerning this process,  there has been what some have called a deification of the
market  (Cox,  2016).  This  absolute  faith in  the market  has  come from the way that
economics is  taught today as a simple demand and supply dynamic (Watson, 2018).
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Markets  are  thus  given divine  qualities  and presented as  the  mechanism by which
efficient resource allocation will come about. As Leys (2001) points out, in all areas of
public  policy,  politics  have become market-driven,  although the role  of  the market
seems stronger in some economies than others. 
12 Studies  of  capitalist  economies  have  identified  two  opposing  types  of  capitalist
economies : "co-ordinated market economies (CMEs)" and "liberal market economies
(LMEs)" (Hall and Soskice, 2001). CMEs are led by non-market institutions, they tend to
coordinate with labor unions to bargain wages at the industrial or national level and
inter-firm relations are important.  LMEs on the other hand tend to turn to market
institutions. Both Canada and Britain have been described as LME economies, which has
meant maximum exposure to market forces (Leys, 2001). Hall and Soskice argue that in
Anglo-Saxon economies where business coordination was less well organized than in
CMEs,  governments  were  forced  to  implement  deregulation  measures  to  remain
internationally competitive. Added to this, the introduction of New Public Management
(NPM)  techniques  in  both  Canada  and  the  UK  has  also  led  to  the  blurring  of  the
boundaries between the public and private spheres. There was a significant will on the
part of  the  British  government  from  the  1980s  onwards  to  promote  global  capital
mobility and to expose the economy to global market forces,  even in areas such as
public  services  where  conventional  market  systems  are  often  considered  to  be
unsuitable. Leys (2001) argues that the British government under Margaret Thatcher
decided to play a leading role in the construction of a global economy. The result has
been a  significant  increase  in  the  privatization of  key  government  sectors  and the
marketization  and  commodification  of  other  areas  such  as  health  and  education.
Canada  has  also  privatized  large  segments  of  the  public  sector,  developed  public-
private partnerships, and commercialized water, electricity, transport, and security. In
Manitoba, there are increasing calls to privatize the health system and more and more
funds are being invested in private schooling in British Columbia. Renewable energy is
managed by the private sector in Ontario (McDonald, 2016). However, as structuralists
such as Prebisch identified as early as the 1940s, market forces alone are unable to
correct  the  asymmetries  they  reproduce  in  the  area  of  international  trade  and
development (Prebisch, 1946). 
 
03. Literature Review of risks to the international
liberalization of health service supply
13 The  incompatibility  between  priorities  regarding  trade  and  investment  and  health
policy has been largely documented. There is significant literature that supports the
thesis that gains in income, goods, and services from trade have had a net negative
impact on social  welfare and population health because of  the unevenness of  gains
(Andrews and Chaifetz, 2013 ; Blouin et al. 2009 ; Labonté, 2004 ; Labonté et al. 2009.,
Shaffer et al., 2005 ; Smith et al. 2009 ; Stiglitz, 2006 ; Stiglitz, 2009). 
14 Overall, quantitative analysis and several health impact assessments have illustrated
that trade and investment agreements may result in unequal access to health services
and increased public bads (Labonté R, Schram A, Ruckert A., 2016 ; Hirono K et al. 2016 ;
Baker P et al. 2016 ; Weiss M., 2015 ; Smith R.D., 2012 ; Schram A et al., 2015 ; Schram A et
al., 2013 ; Thow and Gleeson 2017.). This is a result of provisions that may limit access to
medicines (Baker 2016 ; Gleeson et al. 2013 ; Thow and Gleeson 2017), constrain policy
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space for health, and limit the scope that governments have to pursue public health
goals (Thow et al., 2015 ; Thow et al. 2014 ; Koisuvalo, 2014). A point that a number of
these studies make is that the threats to public health systems tend to be greater for
those countries that have significantly liberalized their public services. 
15 Moreover, case studies of other countries have shown that an internationalized profit-
oriented health system tends to distort the domestic market for healthcare. The US
market is a case in point where highly specialized and profitable healthcare has been
developed. The market has developed a wide range of exportable specialist  medical
techniques, devices, and highly qualified and specialized personnel, but the national
health system remains one of the most inefficient and costly in the developed world
(OECD 2019). Sasha Issenberg (2016, p. 70) shows how the same problem has emerged in
Israel,  which  has  become  a  haven  for  medical  tourists.  The  latter  enjoy  medical
treatment  far  superior  to  that  received  by  the  average  Israeli.  For  less  developed
countries the risk is even greater. In West Africa, one of the causes of the disastrous
Ebola  crisis  was  the  state  of  domestic  hospitals.  Since  many  local  elites  went  for
treatment abroad and opted out of local hospitals, the latter became underfunded and
dysfunctional. 
16 In addition, Lunt et al.  (2011) have explored the negative externalities of furthering
trade and investment in health services on home country health systems. Indeed, many
distortive effects may arise. Qualified staff may concentrate their attention on health
export  services  that  have  better  pay  and  facilities,  which  diminishes  services  and
facilities in the home country and can perpetuate inequalities. In the case of the UK,
there is a possibility that the best consultants move to the South and London to engage
in expanding lucrative international private health services. In Canada, if physicians
can sustain enough income from profitable medical tourism, they may well switch to
providing private healthcare. Indeed, much of the increase in trade and investment in
health services is medical tourism. There is no agreed definition for medical tourism.
Some  authors  make  a  distinction  between  medical  tourism  (travel  for  wellness,
cosmetic, or other non-essential procedures) and medical travel (travel for essential
procedures) (Ruggeri et al., 2015). In the remainder of this paper, references to medical
tourism will refer to foreign patients’ visits to hospitals or health clinics for treatment
for both essential and non-essential treatment.
17 Yet,  the  recent  Covid-19  pandemic  has  also  given new impetus  for  trade  in  health
services. Gillson and Muramatsu (2020) argue that the pandemic has underlined the
weaknesses of national health systems but at the same time highlighted the need for
further development of cross border e-health services like telemedicine. Equally, they
support  the  cross-border  supply  of  health  professionals  to  alleviate  capacity
constraints on domestic health systems. Yet,  any move towards freeing up trade in
health systems must bear in mind the risks of the development of a two-tier system,
particularly within universal healthcare systems such as those which exist in Canada
and Britain.
 
04. The Canadian public healthcare system and the
blurring of the public and private
18 Canada has a universal system or so-called Saskatchewan single-payer model, which
provides  healthcare  services  that  are  considered  to  be  medically  necessary  to  the
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population. So most hospital interventions are free at the point of use except for some
operations  (mainly  cosmetic),  which  are  not  considered  necessary.  The  Canadian
system  of  health  delivery  is  decentralized  and,  while  overall  the  Medicare  system
protects the population, there are increasing gaps in cover because of the narrow scope
of health services included in universal health coverage (Health Systems in Transition,
2013). Approximately 70 % of health expenditure is covered by this system in Canada
(Health Systems in Transition, 2013).
19 Most  primary healthcare  services  are  delivered by  private  health  providers.  In  the
majority  of  provinces,  a  large  number  of  consultants  have  joined  professional
corporations to increase revenue (Health Systems in Transition, 2013). Support services
to private and acute care also tend to be provided by private operators, for example,
ambulance  services,  food,  and  supplies.  Dentistry  care,  opticians,  psychology,  and
rehabilitation are mainly provided by the private sector. While traditionally hospitals
were  private,  non-profit  making institutions,  the  introduction of  universal  hospital
coverage in 1984 under the Canada Health Act means that hospitals now rely almost
entirely on public funding. Hospitals are mainly owned and operated by the Regional
Health Authorities  (RHAs).  These RHAs are not responsible for collecting taxes,  but
receive  funds  which they redistribute  from the ministries  of  health.  RHAs are  also
responsible for delivering services.
20 However, in the 1990s, government cutbacks led to a reduction in the number of public
sector  healthcare  workers  and  encouraged  the  growth  in  private  sector  activity.
Indeed, since the 2000s, there has been substantial growth in private sector activity.
Glauser (2011) is concerned by what she describes as a "swelling number of private
clinics", which suggests that there is an increasing move towards private healthcare
provision in Canada. The move towards a private system has been described by Cory
Verbauwhede,  a  lawyer  working  for  Médécins  Québécois  pour  le  Régime Public,  as
privatization by stealth. There are no official figures on the number of private clinics at
the national level, but estimates have suggested that there are 300 private clinics in
Quebec, 66 in British Columbia, and 60 in Alberta (Glauser, 2011). While many of these
clinics provide cosmetic services, some are developing into mini hospitals to provide
key surgery such as cataract, knee, and hip surgery (Glauser, 2011). However, one of the
reasons why the growth has not been more significant is the prohibition under the
Canada Health Act for physicians to bill Medicare systems and simultaneously provide
services and charge patients for private clinic services. This has led many doctors to
continue to  work in the public  system because of  their  inability  to  sustain enough
income from working entirely in the private system. 
21 However, evidence suggests as early as 2008 that 90 private clinics were violating the
prohibition  of  public  consultants  working  in  the  private  sector  (Glauser,  2011).
Moreover,  it  has  been  suggested  that  regulators  are  turning  a  blind  eye  to  illegal
practices  because  the  public  system  is  underfunded  which  means  that  desperate
patients are looking elsewhere to receive care more quickly. An investigation into such
malpractice found that approximately 63 % of doctors working at the private clinics
were  also  working  in  the  public  domain  (Tomlinson,  2017).  With  the  expansion  of
private health services and overseas income, there could well be more incentives for
physicians to increase private healthcare work. Funding cuts in the public domain has
meant a decline in capital equipment and better technology in the private sector. The
private sector is also able to sell comprehensive packages of health, including those
Public Healthcare and the Limits to a Canadian-Style Inclusive Trade Agenda
Revue Interventions économiques, 65 | 2021
6
sold in the public domain (hospital services) and preventative healthcare. There is thus
scope to expand the private sector, but the risk is not quite the same as that of the UK
because of the prohibitions of the Canada Health Act. The lifting of such prohibitions in
Britain  has  meant  the  public  health  system  in  this  country  is  perhaps  even  more
vulnerable to the development of private healthcare.
 
05. Liberalizing public healthcare services in Britain
22 Britain like Canada uses a so-called "single-payer" model – whereby healthcare is free
at the point of use, paid for out of taxation, and health workers are employees of the
government.  Britain  has  a  national  health  system that  provides  universal  or  near-
universal  coverage  of  healthcare  for  several  keys  and  costly  health  services :
consultations with doctors and specialists,  tests and examinations,  and surgical  and
therapeutic  procedures.  Public  expenditure covers 80 % of  all  healthcare costs  here
(OECD, 2019). However, dental care and pharmaceutical drugs are often excluded from
coverage (OECD, 2019). 
23 The vast project of liberalization in the 1980s led to a greater public-private mix in the
National  Health Service  (NHS)  and notably  the  introduction of  market  mechanisms
such as public-private partnerships. The creation in 1991 of an internal market within
the National Health Service in Britain furthered this tendency. 
24 With the implementation of the internal market, the basis of funding altered. Hospitals
became  financially  independent  corporations  and  were  responsible  for  making  an
income to survive.  While the creation of an internal market allowed the entry of a
certain number of private providers, there were caps on services contracted out to the
private sector. However, the involvement of the private sector was also increased from
1997 onwards under the New Labour government. Compulsive Competitive Tendering
was replaced by Public-Private Partnerships (PPPs) to outsource services to the private
sector.  The  Prime  Minister’s  Delivery  Unit  was  specifically  set  up  to  manage  and
enforce  performance  management,  performance  indicators,  and  Public  Service
Agreements  (PSAs).  Figures  suggest  that  outsourcing  health  sources  to  private
companies  were  greater  under  New  Labour  than  during  the  previous  Conservative
governments. 
25 The  Health  and  Social  Care  Act  of  2012  also  significantly  extended  the  scope  for
participation from the private sector. This Act lifted the cap that had existed until then
on the amount that NHS hospital trusts and other providers could commission out to
the  private  sector.  It  also  removed the  cap on the  amount  of  private  activity  NHS
consultants could engage in. Figures reported in 2014 after a Freedom of Information
request  made  by  former  shadow  minister,  Gareth  Thomas, showed  that  hospitals
increased private income by 40 % after the lifting of  the cap under the Health and
Social Care Act (Watt, 2014). 
26 In March 2018, another survey of the state of privatization of healthcare in Britain was
carried out by the Centre for Health and the Public Interest (CHPI). It found that the
total income that the NHS had generated from private patients had increased by 16 %
over the four years since the enactment of the Health and Social Care Act of 2012. The
main concern about privatization that emerged from the survey was that 1 % of the
NHS’s 131,000 beds were occupied or put aside for private patients. This may appear
small ; however, the number of NHS beds is constantly falling and total occupancy rates
Public Healthcare and the Limits to a Canadian-Style Inclusive Trade Agenda
Revue Interventions économiques, 65 | 2021
7
are at dangerous levels (95 % or more in winter months), which represents a significant
loss for the treatment of NHS-funded patients (Ewbank et al., 2017). Moreover, there is a
disproportionate  skew  of  private  patients  in  NHS  hospitals  in  London  (60 %  of  all
private income) (CHPI, 2018). London is largely where the most affluent people live and
also a favorite destination for international patients. Enlarging the role of the market
in healthcare in the international sphere is certainly a way in which some centrally-
based NHS hospital  trusts  can increase  private  earnings.  A  freedom of  information
request conducted in July 2018 by the present author found that some trusts earned as
much as 45 % of their income from private international patients. More than 16 trusts
were  also  engaging  in  outward  foreign  investment  (mainly  setting  up  health
infrastructures abroad).
 
06. Increasing the role of the market through trade and
investment agreements
27 Indeed,  in  recent  times,  international  trade  and  investment  have  been  a  channel
through which the role of the market has been extended in public services, increasing
commodification in the latter (Raza, 2016). The European Union has played a significant
role  in  this  drive  towards  liberalization  of  public  services  with  the  creation  of  an
internal market and sectoral directives with the aim of freeing up trade and enhancing
competition within the European Union (Keune et al., 2008). This has led to a blurring of
notions of public and private and has raised questions as to what extent the state has a
role in providing public services.  Governance of public services may thus be left  to
other stakeholders on a national or, increasingly, on an international scale. 
28 This  process  has  also  been supported by  international  agreements  and notably  the
General  Agreement  on  Tariffs  and  Trade  (GATT),  General  Agreement  on  Trade  in
Services  (GATS),  and the creation of  the WTO.  After  a  series  of  Uruguay rounds of
multilateral  trade negotiations in 1994,  the GATT became subsumed into the World
Trade  Organisation  (WTO),  with  a  view  to  further  consolidating  trade  rules  and
principles  (WTO,  2013).  The  main  goals  of  the  WTO  since  its  inception  have  been
implementing  free  trade  by  reducing  tariffs  and  customs  duties,  enhancing
transparency, stable investment, stable trading environments, and non-discrimination
via  the  most-favored  nation  rule  and  national  treatment  rules  (which  prohibit  the
application of discriminatory trading rules between trading partners). The WTO rules
have enabled tariffs to be cut significantly and consequently increased flows of goods
and services (WTO, 2013 ;  Friel  et  al.,  2015).  Since its  creation,  24 multilateral  trade
agreements have thus been created, binding countries on a number of issues. The most
significant agreements have been the General Agreement on Trade in Services (GATS),
Trade-Related Aspects  of  Intellectual  Property  Rights  (TRIPS),  Technical  Barriers  to
Trade  (TBT),  Sanitary  and  Phytosanitary  (SPS)  Agreement,  the  Agreement  on
Agriculture, and a dispute settlement system (WTO, 2014 ; Friel et al., 2015). There has
also  been  a  significant  increase  in  Foreign  Direct  Investment  (FDI)  calling  for
agreements to protect investors from political risks (protection against discrimination,
protection against  expropriation without compensation,  protection from unfair  and
unreasonable treatment, and a guarantee of free movement of capital). This has led to
the  signing  of  Bilateral  Investment  Treatments  (BITs)  or  International  Investment
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Agreements (IIAs). Free Trade Agreements also include specific provisions relating to
investment (Friel et al., 2015). 
29 However, there does seem to be an inherent desire in countries worldwide to protect
the policy space in the area of healthcare policy formulation and this may explain why
efforts  have  been  made  to  protect  and  thus  exclude  healthcare  from  trade  and
investment deals. Fewer than 50 of the WTO’s members have made commitments in
one of the four health services sub-sectors (WTO, 2020a). Health is the sector in which
there are the fewest overall commitments. Moreover, European and Canadian interest
groups have campaigned against furthering trade and investment in health services
through inclusion in trade deals ever since 2000 during the GATS negotiations. From
2002  to  2003  the  Directorate  General  (DG)  Trade  did  refine  the  GATS  position  by
excluding  public  services  from  negotiations.  DG  Trade  press  releases  from  2003
onwards have underlined that "public services" "are fully safeguarded" and that no
commitments  have  been  made  in  health  or  education.  Exclusion  of  public  health
services has also been at the heart of more recent trade and investment deals. In the
resolution on Trade in Services Agreement (TiSA), the European Commission promises
to introduce a "gold standard" clause to exclude public services from the scope of trade
agreements irrespective of how they are supplied. CETA also has a public sector carve-
out, which exempts "services supplied in the exercise of governmental authority" from
the  application  of  the  chapter  on  trade  in  services,  and  certain  elements  of  the
investment chapter (European Commission, 2020). 
30 Nevertheless, civil society and researchers are still raising concerns about regulatory
loopholes. Indeed, one of the key issues was the irreversible nature of the privatization
of public services due to the inclusion of a negative listing and a ratchet clause. Under
the  negative  listing,  trade  agreements  apply  to  all  areas,  unless  they are  explicitly
exempted in the agreement. A negative listing means only exceptions will be listed with
no further exceptions after the deal is signed, which could have a significant impact if
public services are not included (Maier de Kruijff et al., 2016). The negative listing was a
key  innovation  of  the  CETA  agreement,  for  example.  A  "ratchet  clause"  has  been
included in the CETA agreement and is planned for TiSA, which means that if a country
decides  to  liberalize  the  market  for  a  public  service  then  that  level  of  market
liberalization  must  be  maintained  and  cannot  be  reversed,  i.e.  services  cannot  be
brought back into the domain of the state. Maier de Kruijff et al. (2016) underline the
essential  threat  to  democratic  governance  that  this  implies.  A  government  that  is
democratically elected in a country may cease to make decisions to the extent to which
a public service is provided to its citizens. 
31 Investor protection has also been an issue raised by academics and civil society. The
fear  is  that  the  Investor-State  Dispute  Settlement  (ISDS)  could  enable  companies
investing in a specific country to bypass national jurisdiction and challenge a national
government via undemocratic tribunals.  The underlying aim of including ISDS is  to
provide a neutral international arbitration procedure to resolve conflicts. Many trade
and investment agreements contain forms of ISDS. However, this may also be a way in
which  investors  can  sue  governments  or  gain  the  upper  hand  and  constrain
governments’ ability to regulate, especially in sensitive areas such as health services
(Maier de Kruijff et al., 2016). 
32 The European Public Health Alliance (EPHA) notes for example that while Article 8.9 of
CETA reaffirms the right for national governments to regulate in the area of public
Public Healthcare and the Limits to a Canadian-Style Inclusive Trade Agenda
Revue Interventions économiques, 65 | 2021
9
health, the government would still have to compensate international companies if their
investment rights are infringed. For example, under the North American Free Trade
Agreement (NAFTA),  Canada was sued 35 times and often in cases regarding public
health. In 1997, Ethyl Corp challenged a Canadian ban on the gasoline additive because
of its negative effects as a neurotoxin (EPHA, 2016). Canada settled and paid 13 million
dollars in damages. In the Eli  Lilly case in 2013, Canada’s attempt to invalidate a US
patent was challenged before an arbitral tribunal (UNCTAD, 2013). All claims which the
US pharmaceutical company asserted against Canada were dismissed. Nevertheless, the
arbitral proceedings of this case set future standards for litigation of patents governed
by international investment law. During these proceedings, the arbitral tribunal make
it  clear  that  state  courts  should  follow the  provisions  of  Chapter  11 of  the  NAFTA
agreement. Canada could therefore well have been held liable for the conduct of its
courts  if  it  had ruled that  they had not  complied with the  standards  of  treatment
established under NAFTA (Musmann, 2017).
33 The other major concern for Canada, which could also represent a threat for Britain
post-Brexit,  is  the  risk  that  Intellectual  Property  Rights  (IPR)  provisions  in  trade
agreements may result in higher prescription costs. IPR were strengthened under the
Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement, negotiated in
1995 under the auspices of the WTO. This agreement provided for a minimum term of
20  years  of  protection  for  patents  on  pharmaceutical  products.  Given  the  risk  of
escalating  prices  of  medication,  the  TRIPS  did  include  safeguards  to  reduce  the
negative impact on access to medicines. There was thus an extension of the TRIPS to
include the Declaration on the TRIPS Agreement and Public Health. This Declaration
granted  member  countries  the  right  to  take  action  to  protect  public  health  and
promote access to medicines. 
34 Canada has the third highest drug costs in the Organisation of Economic Co-operation
and  Development  (OECD)  (Government  of  Canada,  2019).  As  Michael  McBane
underlines, "access to essential medicine and access to generics are key elements in a
sustainable  public  health-care  system.  Canadians  don’t  want  this  traded  away"
(McBane,  2012).  A  large  number of  Canadians  cannot  afford prescribed medication.
Research  carried  out  by  the Angus  Reid  Institute  and  Mindset  Social  Innovation
Foundation found that more than one in five (23 %) of Canadians have either chosen
not to buy medication, skipped doses, or split pills because of the unaffordable price of
medication  (Angus  Reid,  2015).  A  poll  carried  out  in  2019  by  the  Heart  &  Stroke
Foundation  and  the  Canadian  Federation  of  Nurses  Union  (CFNU)  confirmed  these
findings, reporting that nearly one in four (24 %) of Canadian households had taken the
decision not to fill or renew a prescription or take all prescribed drugs because of the
high cost (Heart and Stroke Foundation, 2019). Medicine is not paid for by Medicare,
apart  from  in  hospital,  and  therefore  represents  out-of-pocket  costs  for  some
Canadians because the Canada Healthcare Act does not cover all prescription drugs.
35 In the UK, British citizens do not have to pay for the full costs of prescriptions, and
medication  for  some  chronic  conditions  is  entirely  covered  by  the  NHS.  However,
access to drugs is still problematic. Faced with the spiraling costs of new drugs on the
market, the NHS has been reported to reject a third of all new cancer drugs, which has
meant that cancer patients are unable to access more effective treatment in Britain. It
may be no coincidence that Britain has consistently scored poorly on cancer recovery
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outcomes (OECD, 2019). The NHS also practices a price cap, which prevents access to
new drugs (mainly those protected by IPR) (Thaysen, 2017).
36 The conclusion of FTAs such as CETA or CPTPP has led to the development of greater
IPR protection, which can pose significant risks of escalating medication prices. This is
a cause for concern given that access to medication is already somewhat compromised
in Canada and the UK. All member countries of CPTPP must provide a grace period of
one  year  before  a  patent  filing  date,  during  which  time  public  disclosure  by  the
inventor or their assignee has to be disregarded to determine whether the invention is
new.  Besides,  for  the  period  that  marketing  approval  is  being  secured  for  a  new
product,  the  applicant  may  be  required  to  submit  undisclosed  tests  or  other  data
concerning the safety and efficacy of such a product. The CPTPP thus obliges countries
to protect such tests or data for at least 10 years from the date of marketing approval of
the product. Such provisions could lead to off-patent medicines having exclusive rights
and  again  prevent  the  market  entry  of  generic  versions  because  the  companies
supplying  these  generic  versions  are  unable  to  replicate  such  costly  and  time-
consuming tests to obtain marketing approval. There would therefore seem to be great
risks for both Canada and the UK if it joins the CPTPP post Brexit. 
37 Moreover, Lexchin and Gagnon (2014) estimated that CETA’s provisions would increase
Canadian drug costs by between 6.2 % and 12.9 % from 2023. This is essentially because
patients would have to meet two price hikes : the rising drug costs and the subsequent
increase in federal  taxes.  The authors  also contend that  with increased drug costs,
provincial  governments  will  be  forced  either  to  restrict  publicly  available  drugs,
transfer costs to patients, or cover the costs by reducing expenditure in other areas of
healthcare provision. 
 
07. Extension of the private health sector and the
creation of a two-tier healthcare system 
38 Yet  beyond  the  impact  of  the  potential  for  free  trade  agreements  to  lock  in
liberalization  and result  in  uneven access  to  essential  medicines,  the  furthering  of
trade and investment in services thanks to FTAs could more generally result in a two-
tier  healthcare  market.  Many  of  the  provisions  of  trade  agreements  that  claim  to
"exclude to protect" actually mask submerged or shadow institutional processes. Even
the  existing  agreement  of  the  GATS  leaves  enough  scope  for  nations  with  a  high
penetration of the market in public health services,  such as Canada and the UK, to
extend trade and development in health services. The marketization of health services
has enabled the expansion and commercialization of healthcare according to Mode 3 of
the WTO Trade in services framework. The GATS distinguishes between four modes of
supplying services : cross-border trade, consumption abroad, commercial presence, and
presence of natural persons. Mode 3 involves the establishment of a foreign service
provider in a host country. This form of supply can thus generate additional foreign
direct  investment,  help upgrade healthcare infrastructure,  create jobs,  and transfer
know-how and medical expertise (WTO, 2020b). Mode 2 of the WTO framework, which
is  the  consumption  of  services  abroad,  has  also  grown  thanks  to  the  increasing
openness of the public sector with the marketization of public services in general and
further  liberalization  since  2012  with  the  Health  and  Social  Care  Act.  The  GATS
agreement was perhaps the first step to providing a common framework for health
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services : including provisions on health insurance, hospital services, telemedicine, etc.
(WTO, 2013). However, it has also been highly criticized for not taking into account the
specific nature of health policy in different countries and for transferring governance
of public health systems away from national governments (Friel et al., 2015). The move
towards  inclusiveness  of  health  services  in  international  trade  can  be  seen  as
furthering the  exchange of  health  services  at  the  expense  of  public  provision.  The
privatization of public healthcare is thus underway with the possibility of welcoming
foreign patients, even if this does not yet amount to a significant share of healthcare
services in the UK and Canada. There has also been increasing involvement in outward
foreign direct investment. 
 
08. How health and institutional actors further
international liberalization 
39 Significant protest from civil society groups about including public services in the trade
deals  has  meant  that  states  have  made  commitments  to  protect  public  healthcare
services from the liberalization process in recent FTAs. However, this has not stemmed
the commercialization of healthcare abroad with somewhat "submerged" or "shadow"
processes underway. The statements about protecting healthcare in trade and
investment deals are perhaps not telling the full  story or quite simply ignoring the
multilevel dynamics at play in the internationalization of health services beyond trade
policymaking. 
40 The British government would seem to be intent on furthering trade and investment in
the NHS abroad and indeed the marketing of health services to try and reduce the
burden of  public  healthcare  provision.  This  is  evident  from the  support  for  recent
outward foreign direct investment in which hospital trusts are encouraged to engage.
Only the provision of public NHS services is protected in these trade deals, but there is
still plenty of scope to develop a private market within the NHS as the latter has begun
to develop a two-tier system.
41 A key player in the furthering of trade and investment in healthcare, since 2012 and the
introduction of the Health and Social Care Act, has been Healthcare UK. Healthcare UK
is a joint initiative of the Department of Health (DH), UK Trade and Investment (UKTI),
and NHS England. Until 2017, Healthcare UK was nevertheless presented as a separate
entity with a website disassociated from the government department.  However,  the
organization has now been fully integrated onto the government’s website. 
42 Both private healthcare providers and the NHS have thus been involved in healthcare
agreements, mainly in countries that are looking to improve the domestic supply. Since
its creation, the organization has made over £ 5bn worth of deals. The key markets are
identified as China with 18 deals, followed by Brazil (11), Saudi Arabia (9), the UAE (7),
and India (4). This mainly involved setting up healthcare infrastructure services but
also  clinical  services,  digital  health,  and education  and training.  The  providers  are
private enterprises but also public sector organizations :  NHS Trusts,  Department of
Health arm’s-length bodies and academic institutions, working closely with Healthcare
UK.  The  organization argues  that  such  exchange  can  strengthen  global  health  by
sharing  key  infrastructures  and  healthcare  in  emerging  economies  and  bringing
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revenue back to the UK, which could be spent on public healthcare (Healthcare UK,
2017).
43 Healthcare  UK’s  principal  aim  is  to  increase  the  UK’s  share  of  the  growing  global
healthcare  market.  They  act  as  "the  bridge  between  international  demand  for
healthcare services, systems and infrastructure and the rich pool of UK know-how and
capability  in  these  fields"  (Healthcare  UK,  2017).  They  are  principally  engaged  in
promoting  the  UK  healthcare  sector  in  overseas  markets  through  seminars,
conferences,  and the setting up of  business deals.  They promote the UK’s "thriving
commercial healthcare industry and the world-renowned academic sector". They also
act  as  an  advisory  body  to  NHS  institutions  and  other  organizations  on  political,
commercial,  and  cultural  issues  to  facilitate  market  access.  They  promote  five  key
areas :  healthcare  infrastructure  services,  clinical  services,  digital  health,  education
and training, and health systems development.
44 Healthcare UK promotes the furthering of trade and investment, even within the public
health domain, stating that the NHS has been furthering trade in health services ever
since the 1970s with the Department of Health’s "Exporting the NHS". Such a document
was published in response to requests  made to best-performing NHS organizations,
such  as  St  Thomas’  Hospital,  to  invest  in  healthcare  in  Middle  Eastern  countries.
Healthcare  UK  claims  that  the  benefits  can  accrue  back  to  the  British  healthcare
system, securing over £ 5bn for the UK economy, with £ 235m reinvested back into the
NHS and other public-sector bodies. They admit that the profits may be centralized in
London with major London trusts and foundations winning most of the work abroad
(Kings  College  Hospital,  Moorfields,  Guy’s  &  St  Thomas’  and  Great  Ormond  Street
Hospital). However, a few regional players have also been successful (such as Mersey
Care  and  Alder  Hey  Children’s  Hospital  in  Liverpool,  Leeds  Teaching  Hospital,  and
Northumbria Healthcare) (Healthcare UK, 2016). 
45 Healthcare UK argues that there is scope for expanding outward direct investment and
inward  investment  (receiving  foreign  patients  in  these  establishments  by  creating
private units) because international demand for better and more efficient healthcare is
continually growing with the rise in elderly populations and long-term and chronic
illnesses. The organization claims that inward investment will enable it to share best
practices of an equitable health system with emerging nations. In their preamble to a
report entitled "Enhancing the NHS through International Engagement" (Healthcare
UK, 2016), the organization argues that such ventures also enable NHS professionals to
learn  thanks  to  the  challenges  of  delivering  healthcare  in  different  markets.  They
contend such experiences can provide developmental opportunities for UK staff who
can learn new skills and gain transferable experiences as well as enhancing the global
reputation of the NHS.
46 Healthcare UK also  argues that  it  identifies  and manages  the risks  of  international
ventures and offers advice to NHS trusts engaging in such transactions. It claims to
ensure  that  the  quality  of  NHS  services  provided  to  the  British  public  is  not
compromised by sharing NHS expertise abroad. However, the series of risks identified
in the organization’s manual are mainly concerned with marketing the NHS as a brand
name and externalization risks, but it does not deal with the reconfiguration of the
public  health  system  implied  by  extending  trade  and  investment  in  public  health
services. Healthcare UK does urge trusts to ensure that they are "effectively able to
balance workforce requirements  for  clinical  and managerial  delivery outside of  the
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NHS with day-to-day requirements for core clinical delivery for the NHS" (Healthcare
UK, 2016,  p. 32).  But  from a micro-perspective,  it  seems rather ambitious to expect
individual organizations (hospital trusts and the like) to be able to estimate the wider
risks involved in furthering trade and investment in NHS services. 
47 While  the  Canada  Act  prevents  public  consultants  from engaging  in  private  sector
activities, the crowding out of the public sector by the private is also a risk in Canada
and  could  be  increased  by  the  furthering  of  trade  and  investment  within  PTAs.
Collaborations, for example between Manitoba’s extensive private health services and
Asia, is a case in point. The Manitoba Wellness Institutes at Seven Oaks General Hospital
entered into a joint venture with the China Hospital Association in 2011. It was seen as
an opening for other public health facilities in Canada to engage in overseas ventures.
Like Britain, Canada is looking to increase the number of wealthy foreigners who come
to their country for medical treatment. For example, the University Health Network
(UHN)  treated  621  foreign  patients  between  2011  and  2015  and  raised  revenue  of
around $ 30 million (UHN, 2014). Colleen Flood, a professor in Health Law and Policy at
the University of Ottawa argues that the practice of increasing trade in healthcare can
weaken the quality of Medicare for Canadians. The same fear that has been underlined
in the UK case is that even if there is some reinvestment into the public sector, beds
may  be  reserved  for  medical  tourists  rather  than  Canadians  relying  on  the  public
system. She suggests that if Canada’s medical tourism is extended, it could indeed "eat
into the public health system" and lead to more doctors moving into private practice
because of the prospect of earning better money (Flood, 2015). 
48 Many Canadians are also reported to be leaving the country for medical  treatment
abroad to avoid long waiting lists. According to an annual survey of physicians in 12
specialty  areas,  an  estimated  63,459  Canadians  received  non-emergency  medical
treatment  abroad  in  2016  (Feixue  and  Labrie,  2017).  Outward  medical  tourism  can
however be detrimental to the Canadian healthcare system too. A study published in
the Canadian Journal of Surgery estimated that over $ 560,000 was spent putting right
bariatric surgery in Canada between 2012 and 2013 when medical tourists came back
home (Kim et al., 2013). A similar investigation in Britain found that the mean cost to
the NHS of putting right failed cosmetic tourism carried out abroad was £ 6,360 (Miyagi,
Auberson, Patel and Malata, 2012).
49 While it has been argued that engaging in trade and investment in health services may
mobilize additional funds for cash-starved public sectors, it is more likely to fragment
the healthcare system and lead to disjointed information and practice because of the
provision of a two-tier and competing system between those services provided by the
public sector and those provided by the private sector (Allottey et al., 2012, Missoni
2012). While health tourism may promote economic growth in the destination country,
at the same time it can also give incentives for health workers to move from rural to
urban settings. The rise in the number of private health facilities for foreign consumers
will inevitably worsen national residents’ access to health services and, in particular,
those groups of the population that cannot afford private care. There is some evidence
that this might already be the case. As Glauser (2011) underlines, an increase in medical
tourism, which may be enhanced through further liberalization in trade deals, can be
seen as representing a shift to for-profit private healthcare. She argues that creating a
second-tier contravenes the principles of Medicare in Canada and exacerbates unequal
access to healthcare. The author contends that if human resources (doctors, nurses,
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and administrators) are focused on medical tourism, this will divert attention from the
public healthcare system. Likewise, if Canadians seek care abroad, which is increasingly
possible thanks to GATS and PTAs, healthcare providers in Canada may find it difficult
to coordinate care.
50 The British NHS is facing the same problems, which could intensify as trade is freed up
under these new trade deals. The NHS Code of Practice for Private Patients states that
"provision of services for private patients should not prejudice the interests of NHS
patients or disrupt NHS services", and "NHS commitments should take precedence over
private work" (UK Department of Health ; 2004, p. 1). In practice, there have been some
adverse effects  observed.  A Centre for Health and the Public  Interest  (CHPI)  report
notes that junior doctors, interviewed as part of the investigation into the privatization
of the NHS, admitted that taking notes on private patients tended to take up a lot of
time.  This  left  less  time to deal  with NHS patients  (CHPI,  2018).  Senior consultants
seemed to be spending more time with private patients and encouraged their teams to
do  so  to  sustain  a  private  income.  The  overall  conclusion  was  that  so  long  as  the
number of private patients remains low, it should not put pressure on public patients.
However,  with  the  future  threat  of  NHS funding  per  patient  falling  and a  possible
increase in international private patients thanks to the liberalization of trade through
PTAs, different levels of treatment may well emerge. The other risk is that currently
there is no law stating that private patients have to wait as long as public patients for
treatment. This could potentially mean that public patients wait longer for treatment.
The increasing number of private patients seeking high-quality health services in NHS
trusts, especially in London, may accentuate this problem.
 
09. Conclusion 
51 Comprehensive  trade  and  investment  agreements  have  been  seen  as  essential  to
advancing  the  globalization  of  healthcare.  Such  deals  starting  with  the  GATS  and
furthered by the recent comprehensive agreements such as CETA have already enabled
the commodification of healthcare sectors around the world, but sufficient measures
have not  been taken to  inform and involve locally  affected populations and supra-
national regional bodies of the dangers. Also, treaties and bilateral investment deals
have also enabled the furthering of services trade and investment in health services.
52 Beyond the specific risks posed by ISDS, the extension of IPR in PTAs and other trade
and investment deals, the crowding out of the public sector by the increasing scope for
public sector consultants to work towards supplying healthcare to the international
market  should  be  taken  seriously.  This  is,  even  more,  the  case  gives  the  current
pressures on public health systems owing to the Covid-19 crisis.
53 The key risks of  furthering trade in health services,  whether it  be in the public  or
private domain, are a resulting two-tier health system, disincentives for practitioners
to engage in the public sector, and, consequently, a move towards the private sector.
The reconfiguration of the public health system in Britain and recent legislation to
open up public  health  services  to  the  private sector  have  made Britain  even more
vulnerable to such risks. 
54 While public services may be excluded and thus protected in free trade agreements, the
reality is that said services are still at risk because of current legislation which enables
private  and  public  health  providers  alike  to  further  trade  and  investment  largely
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unheeded.  Progressive  trade  deals  that  promise  to  protect  healthcare  from  the
furthering  of  trade  and  investment  simply  overshadow  the  issue  that  there  are
increasing incentives for public sector physicians to engage in international trade and
investment and the state would seem to be prepared to support such processes because
of  the  narrative  of  the  superiority  of  the  market.  The  British  and Canadian public
healthcare systems have progressively been developing into a complex mix of public
and private services in recent years.  Trade policy carve-outs do not therefore fully
exclude the public good as intended. 
55 The Global Healthcare Policy and Management Forum held in South Korea in October
2016  concluded  that  there  are  clear  concerns  about  the  extent  to  which  the
internationalization of healthcare or "medical tourism", furthered through free trade
agreements,  exacerbates  health inequities.  To date,  no institution has established a
valid  method  of  qualitative  and/or  quantitative  measures  to  evaluate  these  effects
(Crooks et al., 2017). 
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ABSTRACTS
One of the key tenets of the Progressive Trade Policy agenda (PTA), set forth in the Canadian
government’s  Report  of  the Standing Committee on International  Trade on the Trans-Pacific
Partnership, was the safeguarding of the national government’s rights to regulate in the area of
public services, including health services. However, the extent to which such an agenda protects
public health care provision is far from certain. While the internationalization of health services
has the potential to increase the supply of health services worldwide, a lack of global governance
mechanisms to protect the health, and failure to take into account the risks to public health of
the internationalization of health services may be highly detrimental to the health of trading
nations. This paper draws on theoretical and empirical insights from both health policy research
and international political science to analyze the potential effects of further trade openness on
public healthcare provision in Canada and the UK. 
L’un des principes clés du programme de politique commerciale progressiste (PTA), énoncé dans
le rapport du gouvernement canadien du Comité permanent du commerce international sur le
partenariat transpacifique, était la sauvegarde des droits du gouvernement national à légiférer
dans  le  domaine  des  services  publics,  y  compris les  services  de  santé.  Toutefois,  qu’un  tel
programme  puisse  protéger  les  services  de  santé  publique  est  loin  d’être  certain.  Certes,
l’internationalisation des services de santé peut accroître l’offre de services de santé dans le
monde entier. Toutefois, l’absence de mécanismes de gouvernance mondiale pour protéger la
santé et l’absence de prise en compte des risques pour la santé publique de l’internationalisation
des services de santé peuvent être très préjudiciables à la santé des pays commerçants. Cet article
s’appuie sur des données théoriques et empiriques issues de la recherche sur les politiques de
santé  et  de  la  science  politique  internationale  pour  analyser  les  effets  potentiels  d’une  plus
grande ouverture  commerciale  sur  la  prestation des  soins  de  santé  publics  au  Canada et  au
Royaume-Uni. 
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